Taylor-made production of pyrimidine nucleoside-5'-monophosphate analogues by highly stabilized mutant uracil phosphoribosyltransferase from Toxoplasma gondii
| dc.contributor.author | Acosta Bueno, Javier | |
| dc.contributor.author | Nguyen, Kim | |
| dc.contributor.author | Spitale, Robert C. | |
| dc.contributor.author | Fernández Lucas, Jesús | |
| dc.date.accessioned | 2023-06-07T17:16:11Z | |
| dc.date.available | 2023-06-07T17:16:11Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Nowadays, enzymatic synthesis of nucleotides is an efficient and sustainable alternative to chemical methodologies. In this regard, after the biochemical characterization of wild-type and mutant uracil phosphoribosyltransferases from Toxoplasma gondii (TgUPRT, TgUPRT2, and TgUPRT3), TgUPRT2 was selected as the optimal candidate (69.5 IU mg-1, UMP synthesis) for structure-guided immobilization onto Ni2+ chelate (MNiUPRT2) and onto glutaraldehyde-activated microparticles (MGlUPRT2). Among resulting derivatives, MNiUPRT23 (6127 IU g-1biocat; 92% retained activity; 3-5 fold enhanced stability at 50-60 °C) and MGlUPRT2N (3711 IU g-1biocat; 27% retained activity; 8-20 fold enhanced stability at 50-60 °C) displayed the best operability. Moreover, the enzymatic synthesis of different pyrimidine NMPs was performed. Finally, the reusability of both derivatives in 5-FUMP synthesis (MNiUPRT23, 80% retained activity after 7 cycles, 5 min; MGlUPRT2N, 70% retained activity after 10 cycles, 20 min) was carried out at short times. | spa |
| dc.description.filiation | UEM | spa |
| dc.description.impact | 11.889 Q1 JCR 2021 | spa |
| dc.description.impact | 2.354 Q1 SJR 2021 | spa |
| dc.description.impact | No data IDR 2021 | spa |
| dc.description.sponsorship | Santander Foundation (SAN151610) | spa |
| dc.description.sponsorship | Universidad Europea de Madrid (2020/UEM42) | spa |
| dc.description.sponsorship | National Institutes of Health (5R21MH116415) | spa |
| dc.identifier.citation | Acosta, J., Nguyen, K., Spitale, R. C., & Fernández-Lucas, J. (2021). Taylor-made production of pyrimidine nucleoside-5'-monophosphate analogues by highly stabilized mutant uracil phosphoribosyltransferase from Toxoplasma gondii. Bioresource Technology, 339, 125649. https://doi.org/10.1016/j.biortech.2021.125649 | spa |
| dc.identifier.doi | 10.1016/j.biortech.2021.125649 | |
| dc.identifier.issn | 0960-8524 | |
| dc.identifier.issn | 1873-2976 | |
| dc.identifier.uri | http://hdl.handle.net/11268/12123 | |
| dc.language.iso | eng | spa |
| dc.peerreviewed | Si | spa |
| dc.relation.publisherversion | https://doi.org/10.1016/j.biortech.2021.125649 | spa |
| dc.rights.accessRights | restricted access | spa |
| dc.subject.other | Nucleósidos | spa |
| dc.subject.unesco | Biotecnología | spa |
| dc.subject.unesco | Bioquímica | spa |
| dc.title | Taylor-made production of pyrimidine nucleoside-5'-monophosphate analogues by highly stabilized mutant uracil phosphoribosyltransferase from Toxoplasma gondii | spa |
| dc.type | journal article | spa |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 9f17496d-ddb2-4712-80ee-0bec353d0a35 | |
| relation.isAuthorOfPublication | 65bdb4fa-7adf-42ce-b40e-421a62e05239 | |
| relation.isAuthorOfPublication.latestForDiscovery | 9f17496d-ddb2-4712-80ee-0bec353d0a35 |

